Takayasu Arteritis pathophysiology in adults
Takayasu arteritis is a rare, chronic inflammatory disease that primarily affects large arteries, especially the aorta and its main branches. Although it can occur at any age, it predominantly manifests in young adults, most commonly women under 40 years old. The pathophysiology of Takayasu arteritis in adults involves a complex interplay of immune-mediated inflammation, vascular remodeling, and subsequent tissue damage.
The disease process begins with an abnormal immune response targeting the arterial wall. Although the exact trigger remains unknown, genetic predispositions and environmental factors are believed to contribute. Histologically, Takayasu arteritis is characterized by granulomatous inflammation involving the adventitia and media layers of affected arteries. Immune cells such as T lymphocytes, macrophages, and multinucleated giant cells infiltrate these layers, releasing cytokines and enzymes that promote inflammation and tissue destruction.
This inflammatory response leads to structural changes within the arterial wall. The infiltration causes thickening of the vessel wall, primarily through intimal proliferation and fibrosis. As the disease progresses, the inflammation can weaken the vessel wall, resulting in aneurysm formation, or cause significant narrowing (stenosis) of the arterial lumen. The narrowing impairs blood flow to downstream tissues, leading to ischemic symptoms such as claudication, pulselessness, or organ dysfunction depending on the vessels involved.
A hallmark of Takayasu arteritis is the recurring cycle of inflammation and healing. During active phases, inflammatory markers like erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are elevated, reflecting systemic inflammation. These markers often co
rrelate with disease activity and can be useful in monitoring treatment response. As the inflammation subsides, fibrosis and scarring may stabilize the arterial wall, but the structural damage might be irreversible.
The immune-mediated process involves a complex network of cytokines and chemokines that perpetuate arterial inflammation. Th1 and Th17 T-cell responses are prominent, producing cytokines such as interferon-gamma and interleukin-17, which further recruit inflammatory cells to the vessel wall. Additionally, endothelial cells lining the arteries become activated, expressing adhesion molecules that facilitate leukocyte adhesion and infiltration, amplifying the inflammatory cascade.
Over time, the ongoing inflammation and repair processes lead to vessel remodeling, with intimal hyperplasia and fibrosis causing stenosis, or in some cases, occlusion of major arteries. This vascular damage underpins the clinical manifestations of Takayasu arteritis, including differences in blood pressure in limbs, absent pulses, hypertension due to renal artery involvement, and ischemic symptoms in various organs.
In summary, Takayasu arteritis in adults is a manifestation of an autoimmune-driven vasculitis characterized by granulomatous inflammation of large arteries. The immune response causes structural damage, leading to vessel stenosis, aneurysm formation, and ischemia. Understanding these pathological mechanisms is crucial for timely diagnosis and effective management, which often involves immunosuppressive therapy aimed at controlling inflammation and preventing irreversible vascular damage.